<?xml version="1.0" encoding="UTF-8"?>
<results title="mena-migration">
 <result pre="hepatitis C virus (HCV) genotypes in the Middle East and" exact="North Africa" post="(MENA). Source of data was a database of HCV"/>
 <result pre="of data was a database of HCV genotype studies in" exact="MENA" post="populated using a series of systematic literature searches. Pooled"/>
 <result pre="centered in Egypt, and genotype 1 pattern ubiquitous in most" exact="MENA" post="countries. epidemiology genotype Hepatitis C virus meta‐analysis Middle East"/>
 <result pre="countries. epidemiology genotype Hepatitis C virus meta‐analysis Middle East and" exact="North Africa" post="transmission Funding Qatar National Research Fund9‐040‐3‐008 fig-count: table-count: page-count:"/>
 <result pre="million people are chronically infected, globally.5 The Middle East and" exact="North Africa" post="(MENA) region is the most affected by HCV infection,"/>
 <result pre="characterize the distribution, diversity, and patterns of HCV genotypes in" exact="MENA" post="by (1) estimating the country‐specific pooled mean proportions of"/>
 <result pre="genotype. This study was conducted under the umbrella of the" exact="MENA" post="HCV Epidemiology Synthesis Project, an on‐going effort to characterize"/>
 <result pre="sources The source of data for our study was the" exact="MENA" post="HCV Epidemiology Synthesis Project database, a comprehensive database of"/>
 <result pre="RNA prevalence studies among 19 593 HCV antibody positive participants. The" exact="MENA" post="HCV Epidemiology Synthesis Project database was populated through a"/>
 <result pre="databases (World Health Organization [WHO] Index Medicus for the Eastern" exact="Mediterranean" post="Region, the Iraqi Academic Scientific Journals’ database, Iran's Scientific"/>
 <result pre="Academic Scientific Journals’ database, Iran's Scientific Information Database, among others)," exact="MENA" post="HIV/AIDS Epidemiology Synthesis Project database,23, 24 abstract archives of"/>
 <result pre="in which HCV was first identified.25, 26 Our definition of" exact="MENA" post="included 24 countries: Afghanistan, Algeria, Bahrain, Djibouti, Egypt, Iran,"/>
 <result pre="HCV antibody prevalence and HCV RNA prevalence sub‐databases of the" exact="MENA" post="HCV Epidemiology Synthesis Project database.12, 13, 14, 15, 16,"/>
 <result pre="the details of the 338 identified HCV genotype studies in" exact="MENA" post="including 82 257 genotyped individuals. Genotype information was available for"/>
 <result pre="hepatitis C virus (HCV) genotype across the Middle East and" exact="North Africa" post="(MENA) Studies Samples Proportion (actual studies) Proportion (meta‐analysis) Heterogeneity"/>
 <result pre="Arabia 23 2652 0.0‐75.0 34.4 27.5‐41.6 213.2 (P &amp;lt; 0.001) 89.7 (85.8‐92.5)" exact="Syria" post="3 674 10.0‐60.7 33.5 12.1‐58.9 13.4 (P &amp;lt; 0.001) 85.0 (55.8‐94.9)"/>
 <result pre="UAE 4 233 26.9‐75.0 52.4 30.8‐73.7 23.5 (P &amp;lt; 0.001) 87.2 (69.4‐94.7)" exact="MENA" post="338 82 257 0.0‐100 30.2 26.8‐33.8 31841 (P &amp;lt; 0.001) 98.9 (98.9‐99.0)"/>
 <result pre="Arabia 23 2652 0.0‐7.4 1.4 0.4‐2.8 49.3 (P &amp;lt; 0.001) 55.3 (28.6‐72.1)" exact="Syria" post="3 674 0.0‐0.8 0.0 0.0‐0.2 0.1 (P = 0.928) Tunisia 22"/>
 <result pre="UAE 4 233 0.0‐33.3 1.2 0.0‐6.5 7.1 (P = 0.067) 58.0 (0.0‐86.0)" exact="MENA" post="338 82 257 0.0‐63.2 2.5 1.6‐3.5 11940.7 (P &amp;lt; 0.001) 97.2 (97.0‐97.3)"/>
 <result pre="Arabia 23 2652 0.0‐33.3 0.8 0.0‐2.3 75.2 (P &amp;lt; 0.001) 70.7 (55.4‐80.8)" exact="Syria" post="3 674 0.0‐1.7 0.3 0.0‐1.2 0.2 (P = 0.903) 0.0 (0.0‐0.0)"/>
 <result pre="UAE 4 233 0.0‐33.6 11.8 0.1‐33.1 32 (P &amp;lt; 0.001) 90.6 (79.0‐95.8)" exact="MENA" post="338 82 257 0.0‐100 26.8 22.4‐31.5 60629.7 (P &amp;lt; 0.001) 99.4 (99.4‐99.5)"/>
 <result pre="Arabia 23 2653 9.4‐90.9 56.6 49.0‐64.0 225.9 (P &amp;lt; 0.001) 90.3 (86.7‐92.9)" exact="Syria" post="3 674 39.3‐60.0 53.8 40.3‐67.1 4.1 (P = 0.127) 51.5 (0.0‐86.0)"/>
 <result pre="UAE 4 233 0.0‐46.3 21.3 5.4‐42.8 25.6 (P &amp;lt; 0.001) 88.3 (72.5‐95.0)" exact="MENA" post="338 82 257 0.0‐100 17.3 14.1‐20.6 43318.8 (P &amp;lt; 0.001) 99.2 (99.2‐99.3)"/>
 <result pre="Arabia 23 2652 0.0‐5.1 0.0 0.0‐0.0 31.1 (P &amp;lt; 0.094) 29.3 (0.0‐57.6)" exact="Syria" post="3 674 0.0‐30.0 7.6 0.0‐23.0 9.1 (P &amp;lt; 0.010) 78.1 (29.4‐93.2)"/>
 <result pre="UAE 4 233 0.0‐0.0 0.0 0.0‐0.0 0.7 (P &amp;lt; 0.875) 0.0 (0.0‐33.7)" exact="MENA" post="338 82 257 0.0‐31.6 0.0 0.0‐0.0 706.8 (P &amp;lt; 0.001) 52.3 (45.9‐57.8)"/>
 <result pre="Arabia 23 2652 0.0‐0.9 0.0 0.0‐0.0 8.2 (P &amp;lt; 0.997) 0.0 (0.0‐0.0)" exact="Syria" post="3 674 0.0‐0.0 0.0 0.0‐0.0 1.3 (P &amp;lt; 0.524) 0.0 (0.0‐83.9)"/>
 <result pre="UAE 4 233 0.0‐0.0 0.0 0.0‐0.0 0.7 (P &amp;lt; 0.875) 0.0 (0.0‐33.7)" exact="MENA" post="338 82 257 0.0‐3.4 0.0 0.0‐0.0 317.3 (P &amp;lt; 0.001) 0.0 (0.0‐7.4)"/>
 <result pre="hepatitis C virus (HCV) genotypes across the Middle East and" exact="North Africa" post="(MENA) region. Legend: ‡ Countries in which less than"/>
 <result pre="virus (HCV) genotype across countries of the Middle East and" exact="North Africa" post="(MENA) region. Legend: Djibouti, Mauritania, Somalia, Sudan, and Yemen"/>
 <result pre="was limited (≤10%) in Pakistan and Egypt. For the whole" exact="MENA" post="sample, the pooled mean proportion for genotype 1 was"/>
 <result pre="3.2.2 Genotype 2 Genotype 2 was not dominant in any" exact="MENA" post="country, but was common in Algeria, Bahrain, Morocco, and"/>
 <result pre="Afghanistan, Iraq, Jordan, Kuwait, Palestine, and Syria. For the whole" exact="MENA" post="sample, the pooled mean proportion for Genotype 2 was"/>
 <result pre="in each of Egypt, Jordan, and Palestine. For the whole" exact="MENA" post="sample, the pooled mean proportion for Genotype 3 was"/>
 <result pre="Tunisia. No cases were observed in Afghanistan. For the whole" exact="MENA" post="sample, the pooled mean proportion for Genotype 4 was"/>
 <result pre="7 Genotype 5 was neither dominant nor common in any" exact="MENA" post="country. It was limited in Syria at 7.6% (95%CI:"/>
 <result pre="nor common in any MENA country. It was limited in" exact="Syria" post="at 7.6% (95%CI: 0.0‐23.0), but otherwise was not observed,"/>
 <result pre="or was observed at extremely low levels, in the remaining" exact="MENA" post="countries. For the whole MENA sample, the pooled mean"/>
 <result pre="low levels, in the remaining MENA countries. For the whole" exact="MENA" post="sample, the pooled mean proportion for Genotype 5 was"/>
 <result pre="pooled mean proportion of 0.0% (95%CI: 0.0‐0.0) for the whole" exact="MENA" post="sample. Genotype 7 was not observed in any country."/>
 <result pre="the genotype diversity across countries of the Middle East and" exact="North Africa" post="(MENA) region, quantified by Shannon Diversity Index. Legend: Djibouti,"/>
 <result pre="estimated number of HCV chronically infected individuals by genotype across" exact="MENA" post="countries. Overall for the region, the largest number of"/>
 <result pre="individuals by genotype across countries of the Middle East and" exact="North Africa" post="(MENA) Number of HCV chronically infected individuals by genotype"/>
 <result pre="7464 (2133‐14 928) 4265 (0‐12 262) 301 762 (261 242‐341 215) 0 (0‐0) 0 (0‐0)" exact="Syria" post="18 502 000 131 860 46 400 (16 760‐81 582) 0 (0‐277) 416 (0‐1662) 74 518"/>
 <result pre="1658 (0‐8983) 16 307 (138‐45 743) 29 436 (29 436‐59 148) 0 (0‐0) 0 (0‐0)" exact="MENA" post="609 377 000 14 127 340 2 049 638 (1 607 916‐2 541 096) 418 935 (228 885‐699 708) 6 043 317 (5 712 239‐6 431 653) 5 604 923"/>
 <result pre="(5 712 239‐6 431 653) 5 604 923 (5 306 028‐5 936 686) 10 527 (0‐38 094) 0 (0‐5157) Genotype distribution in" exact="MENA" post="weighted by population size (%) 14.5 (11.4‐18.0) 3.0 (1.6‐5.0)"/>
 <result pre="pathways of this infection. The distribution of HCV genotypes in" exact="MENA" post="appears to reflect three sub‐regional patterns (Figure 2). The"/>
 <result pre="genotype 1 which is found in the Maghreb sub‐region of" exact="MENA" post="(Algeria, Morocco, Tunisia, and to some extent Libya), part"/>
 <result pre="links with countries outside MENA, such as the Maghreb sub‐region" exact="migration" post="links with Western and Southern Europe.40, 41 There are"/>
 <result pre="limitations. We did not find HCV genotype studies for four" exact="MENA" post="countries, and there were too few studies to conduct"/>
 <result pre="of hepatitis C virus in the World Health Organization Eastern" exact="Mediterranean" post="Region: Implications for strategic action. Eastern Mediterranean Hepatitis C"/>
 <result pre="Health Organization Eastern Mediterranean Region: Implications for strategic action. Eastern" exact="Mediterranean" post="Hepatitis C Virus Epidemiology Synthesis Project. (in press). 2017."/>
 <result pre="the Horn of Africa sub‐region of the Middle East and" exact="North Africa." post="Syst Rev. 2014; 3:1. 24383422 21HigginsJP, GreenS. 2008Cochrane handbook"/>
 <result pre="of Hepatitis C Virus Chronic Infections in Middle East and" exact="North Africa" post="(under preperation). 2017. 34Department of Economic and Social Affairs"/>
 <result pre="necessarily Afghan? J Refug Stud. 2008; 21:43–63. 37ChoucriN. The new" exact="migration" post="in the Middle East: a problem for whom? Int"/>
</results>
